For the past several years, pharmaceutical giant Pfizer has been under investigation by the U.S. Department of Justice for ...

At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...

Three supercharged dividend stocks have the necessary catalysts to make their patient shareholders notably richer.

The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval ...

Pfizer (PFE) closed at $25.32 in the latest trading session, marking a +1.12% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.48% for the day. Elsewhere, the Dow ...

Shares of Pfizer Inc. PFE rose 1.12% to $25.32 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.47% to 6,227.42 and the Dow ...

Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...

Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...

We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...

The release of COVID-19 vaccine results days after the 2020 election may have not been a "coincidence" -- and could have been part of an effort by senior Pfizer executives to "deliberately slow ...